Literature DB >> 1686599

Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.

S B Prusiner1.   

Abstract

Considerable progress has been made in deciphering the role of an abnormal isoform of the prion protein (PrP) in scrapie of animals and Gerstmann-Sträussler syndrome (GSS) of humans. Transgenic (Tg) mice expressing both Syrian hamster (Ha) and mouse (Mo) PrP genes, which encode proteins differing at 16 residues out of 254, were used to probe the mechanism of scrapie prion replication. Four Tg lines expressing HaPrP exhibited distinct incubation times ranging from 48 to 277 days after Ha prion inoculation, which were inversely correlated with the steady-state levels of HaPrP mRNA and HaPrPc. Bioassays of brain extracts from two scrapie-infected Tg lines showed that the prion inoculum dictates which prions are synthesized de novo, even though the cells express both PrP genes. Tg mice inoculated with Ha prions had approximately 10(9) ID50 units of Ha prions per gram of brain while less than 10 units of Mo prions were found. Conversely, Tg mice inoculated with Mo prions had approximately 10(6) ID50 units of Mo prions and less than 10 units of Ha prions. Consistent with the analysis of prion synthesis, Tg mice inoculated with Ha prions exhibited neuropathologic changes characteristic of hamsters with scrapie while Mo prions produced changes similar to those in non-Tg mice with scrapie. Our results argue that species specificity of scrapie prions resides in the primary structure of PrP and formation of infectious prions is initiated by a species-specific interaction between PrPSc in the inoculum and homologous, cellular PrP. Studies on Syrian, Armenian and Chinese hamsters suggest that the domain of the PrP molecule between codons 100 and 120 controls both the length of the incubation time and the deposition of PrP in amyloid plaques. Ataxic GSS in families shows genetic linkage to a mutation in the PrP gene leading to the substitution of Leu for Pro at codon 102. Discovery of a point mutation in the PrP gene from humans with GSS established that GSS is unique among human diseases--it is both genetic and infectious. These results have revised thinking about sporadic Creutzfeldt-Jakob disease (CJD) suggesting it may arise from a somatic mutation. Pulse-chase radiolabeling experiments of scrapie-infected cultures of mouse neuroblastoma cells indicate that protease-resistant PrPSc is synthesized during the chase period with t1/2 approximately 15 h from a protease-sensitive precursor, consistent with the conclusion that PrPc and PrPSc differ due to a post-translational event.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686599

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  5 in total

1.  Creutzfeldt-jakob disease involvement of rolandic cortex: a quantitative apparent diffusion coefficient evaluation.

Authors:  Y-R Lin; G S Young; N-K Chen; W P Dillon; S Wong
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

2.  Detection of disease-associated prion protein in the optic nerve and the adrenal gland of cattle with bovine spongiform encephalopathy by using highly sensitive immunolabeling procedures.

Authors:  Hiroyuki Okada; Yoshifumi Iwamaru; Shigeo Fukuda; Takashi Yokoyama; Shirou Mohri
Journal:  J Histochem Cytochem       Date:  2012-01-19       Impact factor: 2.479

3.  Gaucher disease and parkinsonism, a molecular link theory.

Authors:  Ehud Goldin
Journal:  Mol Genet Metab       Date:  2010-08-10       Impact factor: 4.797

Review 4.  Cofactor molecules: Essential partners for infectious prions.

Authors:  Surachai Supattapone
Journal:  Prog Mol Biol Transl Sci       Date:  2020-08-24       Impact factor: 3.622

5.  Serum-free produced Bovine Herpesvirus type 1 and Bovine Parainfluenza type 3 virus vaccines are efficacious and safe.

Authors:  B Makoschey; J R Patel; P T J A van Gelder
Journal:  Cytotechnology       Date:  2002-09       Impact factor: 2.058

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.